Collaborators People Marli P. Azevedo, MSc, PhD USA Close Marli P. Azevedo, MSc, PhD Marli Azevedo, MSc, PhD is a Research Microbiologist at the National Center for Toxicological Research, Food and Drug Administration in Jefferson, AR. Prior to that, Dr. Azevedo was a research scientist and adjunct assistant professor at Food Animal Health Research Program at The Ohio State University. Dr. Marli Azevedo earned a Ph.D. in virus immunology at The Ohio State University, focusing on vaccine design and enteric virus pathogenesis. Before joining the FDA, Dr. Azevedo dedicated 10 years studying rotavirus immunity. Using gnotobiotic pigs, because of their similarity to human babies. Dr. Azevedo demonstrated viremia and virus infection in the respiratory tract of gnotobiotic piglets after infection with rotavirus. In addition, Dr. Azevedo has studied immune responses to rotavirus and norovirus to identify correlates of protective immunity after vaccination. Furthermore, she has tested and evaluated the immunogenicity and protective efficacy of several candidate human rotavirus vaccines and demonstrated the potential to use these vaccines against rotavirus disease in children. Dr. Azevedo’s current studies are focused on respiratory and enteric viruses. Dr. Azevedo’s lab has cloned and expressed the Spike proteins of SARS-CoV-2, HCoV-NL-63 and HCoV-HUK1. These proteins have been used to generate polyclonal antibody that will allow further studies of coronavirus related disease. Her lab has also generated stable cell lines expressing the non-structural proteins of SARS-CoV-2 and generated cell lines expressing both CD32A and ACE-2 receptor. She is currently investigating the role of spike protein of SARS-CoV-2 on immune mediated pathogenesis and the role of non-structural proteins in COVID-19 morbidity. https://www.fda.gov/about-fda/science-research-nctr/marli-azevedo Ralph Baric, PhD USA Close Ralph Baric, PhD Ralph S. Baric, PhD is the University of North Carolina Kenan Distinguished Professor of Epidemiology in the Gillings School of Global Public Health and Microbiology and Immunology in the School of Medicine. He earned a BS in Zoology and a PhD in Microbiology from North Carolina State University. He performed postdoctoral research in virology and immunology at the University of Southern California before joining the faculty at the University of North Carolina. Dr. Baric’s research focuses on the pathogenesis and emergence mechanisms of RNA viruses, focusing on coronaviruses, flaviviruses and noroviruses. His group has made seminal contributions in virus genetics, identifying host susceptibility genes that regulate virus pathogenesis and emergence, and studying mechanisms of virus cross species transmission, pathogenesis, and virulence. His laboratory participated in the development of several antiviral drugs (remdesivir, molnupiravir), therapeutic antibodies and vaccines (Moderna, Jennsen) targeting the SARS-CoV2 virus which is responsible for the COVID19 pandemic. He is a member of the American Society for Microbiology (ASM) and American Society for Virology. He is a Harvey Weaver Scholar from the National Multiple Sclerosis Society and an Established Investigator from the American Heart Association. He served as chair-elect and subsequently the chair of ASM Division T, RNA viruses. He was a finalist for the World Technology Award, a senior editor for Plos Pathogens, and member of the Journal of Virology editorial board. He was a standing member of the NIH VirB study section from 2005-2009 and is a current member of NIH CMIA study section (2020-). He received the Innovation/Inspiration Award for UNC Faculty Research, the Lifetime achievement award from the Triangle Business Journal, Norma Berryhill Distinguished Lecturer, the UNC System’s O’ Max Gardner Award recipient and the North Carolina’s Governor’s Award recipient. He is a fellow of the American Academy for Microbiology and the National Academy of Sciences. At the Congressional Biomedical Research Congress in early 2020, Baric updated the House of Representative members and staffs regarding the dangers of the SARS-CoV2 pandemic, including research priorities and strategies to mitigate risk Dennis Bente, DVM, PhD USA Close Dennis Bente, DVM, PhD I’m a seasoned and globally-trained virologist, research scientist, and educator working to better understand the effects of tick-borne viruses on human and animal health. My area of expertise is the biocontainment of high consequence virus research and discovery as done through effective project design and management, data analysis and interpretation, and development and implementation of research tools. I enjoy generating new ideas and devising feasible solutions to broadly relevant problems. What makes my research unique is that we are studying the pathogenesis and transmission of tick-borne hemorrhagic fever viruses such as Crimean-Congo hemorrhagic fever under maximum biocontainment conditions in the BSL4 labs at UTMB’s Galveston National Laboratory. I am passionate about serving as a resource and advocate for graduate students and postdoctoral scholars, via career and professional development endeavors. My experience as a PhD scientist allows me to directly relate to and mentor junior scientists as they progress in their studies and professional careers. With a keen focus on their success, The students, postdocs, and visiting scientists who trained in my lab have gone on to distinguished positions in academia, government, and industry. I am skilled in: Instructional design and directing trans-disciplinary educational programs across multi-site campuses, such as the award-winning Field Experience in One Health and Outbreak Investigation course. Diagnostics for tick-borne viruses Development of host-tick transmission models and study of tick-borne virus parthenogenesis Science communication Grant writing Public speaking Faculty Page: https://microbiology.utmb.edu/faculty/dennis-a-bente-dvm-phd LinkedIn: https://www.linkedin.com/in/dennisbente/Twitter: https://twitter.com/BenteLab Instagram: https://www.instagram.com/bente_lab/ Vượng Bùi Nghĩa, DVM, PhD Vietnam Close Vượng Bùi Nghĩa, DVM, PhD Bui Nghia Vuong, DVM, PhD is a researcher in Virology Department in National institute of Veterinary Research (NIVR). As a veterinary virologist, the subjects of his research are the economically important viruses in Vietnam such as infectious bursal disease virus, Japanese encephalitis virus, classical swine fever virus, and avian influenza virus. He has been especially interested in the research on prevention and control of the diseases caused by these viruses i.e. diagnostic methods, epidemiology, vaccine production, and its application. Dr. Bui received his DVM degree, at Vietnam National University of Agriculture and his PhD in Obihiro University of Agriculture and Veterinary Medicine, Japan with major of Animal and Food Hygiene. He has completed successfully the course with an excellent grade. During the PhD course, his study was focused on the surveillance of avian influenza virus and avian paramyxovirus in wild bird flying in Japan and the characterization of the isolates. In addition, He had been involved in some other projects in which he searched for highly functional antiviral materials and development of diagnostic tools for detection of influenza viruses. Based on the extensive past experience on avian influenza viruses, he was offered to continue the research in Obihiro University of Agriculture and Veterinary Medicine, as a post-doctoral researcher. In the university, he was expected to utilize his experiences to significantly advance the ongoing research projects on surveillance of influenza viruses in wild birds, development of highly sensitive and specific diagnosis test for influenza virus. During the past 10 years that Dr. Bui has been working various researches related to viral and viral diseases and he has authored more than 40 peer-reviewed manuscripts. Last 6 years, as a research group leader at Virology in NIVR, he has been in charge of several projects including international and domestic projects in NIVR, which he found very challenging and enjoyable. he has the opportunity to get a deep inside on the important disease and Zoonotic disease and the important role that the Veterinary profession plays. Johnny Callahan, MT(ASCP), PhD USA Close Johnny Callahan, MT(ASCP), PhD Johnny D. Callahan, MT(ASCP), PhD is the Veterinary Diagnostics Business Development Manager, and United States Department of Agriculture / Center of Veterinary Biologics Regulatory Affairs Liaison for Tetracore, Inc., a biotechnology company located in Rockville Maryland. Dr. Callahan’s focus is on the design, development, commercialization, and licensure of laboratory diagnostics for infectious diseases of food animals. In 2021, Tetracore obtained two new USDA licenses: (1) Foot and Mouth Disease Virus RNA Test Kit for use in cattle, swine, and sheep samples; and (2) African Swine Fever Virus DNA Test Kit for use in swine samples. Also in 2021, Tetracore has registered two test kits for use in Mexico (1) Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) RNA Test Kit for detection of RNA in swine samples, and (2) Porcine Epidemic Diarrhea Virus (PEDV) /Transmissible Gastroenteritis Virus (TGEV) / Porcine Deltacoronavirus (PDCoV) Multiplex RNA Test Kit for detection of RNA in swine samples. Dr. Callahan is an American Society for Clinical Pathology (ASCP) registered Medical Technologist with a BS in Medical Technology from the Medical University of South Carolina, Charleston, and Masters and Ph.D. degrees in Pathology from the University of Maryland, Baltimore. His 35+ year career has been focused on applied research in laboratory diagnostics for the detection and characterization of infectious diseases of both humans and animals. At Tetracore, Dr. Callahan's efforts focus on the design and implementation of field validation studies that generate data to support USDA licensure efforts. Other field studies are initiated as needed to demonstrate the value and efficacy of Tetracore’s laboratory diagnostics portfolio. At Tetracore, Dr. Callahan serves as the resident virologist performing virus isolation work using classical techniques in BSL-3 laboratory space and is currently involved in the training of a new crew of young virologists to carry on and expand our diagnostic capacity. Tetracore, Inc. https://www.linkedin.com/in/johnny-callahan-3b593113/ Kristen K. Coleman, PhD USA Close Kristen K. Coleman, PhD Kristen K. Coleman, PhD is an Assistant Research Professor at the University of Maryland School of Public Health and a member of the Public Health Aerobiology, Virology and Exhaled Biomarker Laboratory (PHAB Lab) within the Maryland Institute for Applied Environmental Health. Professor Coleman is a former Research Fellow in the Emerging Infectious Diseases Programme at Duke-NUS Medical School and the Department of Medicine at NUS Yong Loo Lin School of Medicine in Singapore, where she was engaged in research projects in Singapore, Malaysia, Vietnam, China, and the US. Professor Coleman earned her PhD in Biology (Ecology track) from the Department of Environmental Sciences at the University of Toledo. Her doctoral research focused on measuring airborne influenza virus in the school environment. Her current research focuses on the environmental detection, epidemiological surveillance and transmission of emerging and zoonotic pathogens, primarily respiratory viruses such as influenza virus, adenovirus and coronavirus. She has authored several key research papers on airborne transmission of SARS-CoV-2. https://sph.umd.edu/people/kristen-k-colemanhttps://sites.google.com/umd.edu/stopcovid/people#h.l80d6hf7rg0 https://www.linkedin.com/in/kristenkchttps://twitter.com/drkristenkc Matthew Dacso, MD USA Close Matthew Dacso, MD Dr. Dacso is a general internist and an Associate Professor in the Department of Internal Medicine. He also serves as the Director of Academic Partnerships for UTMB Center for Global and Community Health. After completing a B.A. in Music at McGill University, he earned his medical degree from The University of Texas Medical Branch and subsequently completed his internal medicine residency training at the Warren Alpert Medical School of Brown University. He also holds a master's degree in International Development Studies from the University of London School of Oriental and African Studies.As director of the UTMB School of Medicine’s 4-year global health scholarly concentration, he provides mentorship and supervision to trainees participating in international health experiences while collaborating with host partners to design and implement projects that serve their needs. He has applied an approach based in relationships, respect, and integrity to global health-related work taking place in Botswana, Kenya, Uganda, Rwanda, Peru, and the Dominican Republic. He also serves as director for graduate-level courses focused on One Health, outbreak investigation, global health governance/diplomacy, and applied epidemiology.Dr. Dacso also works in the area of capacity-strengthening for emerging epidemics preparedness and response. To this end, he works with a research group based in the Dominican Republic that focuses on acute undifferentiated febrile illnesses, vector-borne disease ecology, and molecular diagnostics for emerging pathogens. He is also a member of UTMB’s Biocontainment Unit response team and the education/training lead for the UTMB Special Pathogens Excellence in Clinical Treatment, Readiness, and Education (SPECTRE) program.Faculty page: https://www.utmb.edu/internalmedicine/divisions/general-medicine/faculty/matt-dacso Twitter: https://twitter.com/DrMattDacso Linkedin: https://www.linkedin.com/in/matt-dacso/ Global Health website: www.utmb.edu/globalhealth Perenlei Enkhbaatar, MD, PhD, FAHA USA Close Perenlei Enkhbaatar, MD, PhD, FAHA Perenlei Enkhbaatar, MD, PhD, FAHA, is a tenured Professor of Department of Anesthesiology, and the Director of the Translational Intensive Care Unit Service Center, the University of Texas Medical Branch at Galveston, TX. He is also a Charles Robert Allen Professor in Anesthesiology. Dr. Enkhbaatar received his MD degree at Saint Petersburg Military Medical Academy, Russia. He received his PhD degree at Kumamoto University Medical School, Kumamoto, Japan. Dr. Enkhbaatar completed his Post-Doctoral training at the University of Texas Medical Branch, Galveston, TX. After the Medical School, he practiced medicine in Mongolia. Dr. Enkhbaatar’s research interest is to investigate pathophysiology of multiorgan dysfunctions during critical illnesses requiring intensive care, such as sepsis, burn trauma, and smoke and toxic gas inhalation. Dr. Enkhbaatar has published more than 170 peer-reviewed manuscripts and book chapters in the related field. Gregory C. Gray, MD, MPH, FIDSA USA Close Gregory C. Gray, MD, MPH, FIDSA Gregory C. Gray MD, MPH, FIDSA is an infectious disease epidemiologist and Professor at the University of Texas Medical Branch in Galveston, Texas. He is affiliated with three Departments: Internal Medicine (Infectious Diseases), Microbiology and Immunology, and Preventive Medicine & Population Health. Professor Gray received his medical degree, at the University of Alabama at Birmingham, School of Medicine, Birmingham, Alabama and his MPH degree from Johns Hopkins School of Hygiene & Public Health, Baltimore, Maryland. He received residency training at Walter Reed Army Institute of Research in Washington, District of Columbia. His medical boards are in Preventive Medicine and Public Health. Dr. Gray has conducted diverse epidemiological studies of infectious diseases for 25 years in 5 continents. He has authored more than 360 peer-reviewed manuscripts and book chapters. His published works have been cited by others more than 11,000 times (H-index 66 by Google Scholar). Much of his work has involved identifying risk factors for occupational diseases, particularly for respiratory virus infections. He has studied numerous occupational groups including farmers, animal breeders, veterinarians, military personnel, turkey workers, poultry workers, horse workers, hunters, and pig workers. A strong supporter for the One Health approach, he has won multiple One Health research and training grants, helped to established centers of One Health (USA, Romania, China) and developed four graduate programs in One Health (PhD, MHS, and certificates). Professor Gray is a Fellow in the Infectious Diseases Society and a member of the Council on Foreign Relations. Related links: https://www.utmb.edu/internalmedicine/divisions/infectious-disease/faculty/gray-gregory-md-mph-fidsahttps://www.utmb.edu/one-health Battsetseg Gonchigoo, DVM, PhD, ScD Mongolia Close Battsetseg Gonchigoo, DVM, PhD, ScD G.Battsetseg is a DVM and Professor at the Institute of veterinary medicine (IVM), Mongolian University of Life Sciences (MULS), Ulaanbaatar, Mongolia. Professor G.Battsetseg received her DVM degree, at the Zoo and Veterinary Institute of Alma-Ata (Now Kazakh National Agrarian University (KazNAU)), Kazakhstan. Her PhD degree from the MULS and ScD – from the Academy of Sciences, Mongolia. She has conducted studies of parasitic and zoonotic diseases for more than 30 years in the country, contributed to a range of research areas under the One Health umbrella. She served as PI/peoject leader for 8 projects involving zoonotic pathogens, disease vectors, animal management, and food safety and also served as a counterpart of 23 national and foreign funded projects. She has authored more than 140 scientific papers in Mongolian, Russian and English including 11 books. Much of her work has involved vector-borne diseases, animal parasitic zoonotic diseases and equine protozoans that affect horse and camel (Camelus bactrianus) populations in Mongolia. In 2016 to 2019 she worked as a Co-PI of an NIH-funded research project “One health Innovation Fellowships for Zoonotic Disease Research in Mongolia”. She developed 2 graduate programs in Veterinary parasitology (MSc and PhD). Kai Huang, MD, PhD USA Close Kai Huang, MD, PhD Kai Huang MD, PhD is the Laboratory Supervisor (lab manager) at the University of Texas Medical Branch in Galveston, Texas. Dr. Huang received his medical degree, at the Guangxi Medical University and his PhD degree from the University of Hong Kong, China. He finished his postdoctoral training in Cornell University. Dr. Huang is interest in the highly pathogenic infectious diseases including but not limited to influenza, coronavirus diseases and Ebola. He has authored more than 44 peer-reviewed manuscripts and book chapters. His published works have been cited by others more than 2,500 times (H-index 20 by Google Scholar). He serves as an editorial board member for 8 journals, edited more than 30 manuscripts, and reviewed at least 260 manuscripts for 40 biomedical journals. https://www.linkedin.com/in/kai-huang-a2224a72/ Gary Kobinger, PhD, OM, MSC USA Close Gary Kobinger, PhD, OM, MSC Gary Kobinger, PhD, is the new Director of the Galveston National Laboratory, one of the largest active biocontainment facilities on an academic campus. Dr. Kobinger has co-authored over 300 peer-reviewed scientific manuscripts and 20 years of experience working in or managing high-containment laboratories. His research presently focuses on developing and testing new vaccine platforms and immune treatments against pathogens of high consequences to global public health. Serving the international community, Dr. Kobinger sits on several committees such as the World Health Organization STAG-IH advisory board. Research Interests Global Health, preparedness and response to infectious events of public health concerns, biosafety and biosecurity.Microbiology Bio Marc-Antoine de La Vega, PhD USA Close Marc-Antoine de La Vega, PhD Marc-Antoine de La Vega, PhD is a postdoctoral fellow at the University of Texas Medical Branch in Galveston, Texas, specifically working at the Galveston National Laboratory under Dr. Gary Kobinger. He is affiliated with the department of Microbiology and Immunology. Dr. de La Vega was trained in Canada, where he received a Bachelor’s degree in Microbiology from the Université de Sherbrooke. His training continued at the University of Manitoba through the initiation of a MSc and a PhD, specifically at the National Microbiology Laboratory. His PhD was later completed at the Université Laval in Québec, Canada following a change of institution by his thesis supervisor, Dr. Kobinger. Most of his work has focused on the parameters influencing transmission of high-consequence pathogens such as Ebola virus, but has contributed to multiple projects regarding vaccine development. Due to his training in high containment facilities, Marc-Antoine has also worked on numerous occasions with multiple not-for-profit organizations such as Global Urgent and Advanced Research and Development, Doctors Without Borders, and the World Health Organization to assist countries (Canada, Guinea, Democratic Republic of the Congo, Burundi) by providing diagnostic training and capabilities in the context of outbreak responses to Ebola virus and SARS-CoV-2. Related linkshttps://publicationslist.org/marcantoine.delavega https://www.utmb.edu/one-health John A. Lednicky, PhD USA Close John A. Lednicky, PhD John A. Lednicky, PhD is a microbiologist and aerovirologist and Research Professor at the University of Florida in Gainesville. His academic appointment is at the Department of Environmental and Global Health and he is affiliated with the University of Florida’s Emerging Pathogens Institute. He received his PhD in microbiology at the University of Texas at Austin, his MS degree in microbiology from the University of Missouri in Kansas City, and his BS degree in microbiology from the University of Miami, Florida. He holds M(ASCP) and RM(NRCM) professional certificates. The current emphasis of Dr.Lednicky’s work center on aerovirology, arbovirology, characterization of hemorrhagic viruses that affect cervids, respiratory virus transmission, and virus discovery. Among his virus discoveries, he prepared molecular clones of many SV40 (Macaque polyomavirus) strains, characterized a new strain of human polyomavirus 9 with a unique enhancer region, discovered human rhinovirus C-51, was the first to isolate Keystone virus from a human, and documented the existence of CHeRI orbiviruses 1 – 3. Dr. Lednicky has studied Chikungunya, Dengue 1 – 4, Madariaga, Mayaro, and Zika viruses and their mosquito vectors. He works closely with engineers on the improvement of air sampling devices and techniques, and on point-of-care devices for diagnostic virology. His research team was the first to conclusively show that COVID-19 patients produce aerosols that contain infectious SARS-CoV-2. His has received funding for his work from agencies such as CDC, DTRA, NBACC, NIH, NSF, as well as from commercial entities. https://egh.phhp.ufl.edu/profile/lednicky-john/ Susan McLellan, MD, MPH USA Close Susan McLellan, MD, MPH Peter Melby, MD USA Close Peter Melby, MD M. Kristen Peek, PhD USA Close M. Kristen Peek, PhD Dr. Kristen Peek is a medical sociologist and social epidemiologist with a PhD in Sociology from Duke University. She has research interests in ethnic differences in the effects of social relationships and stress on health outcomes among older adults. She has served as the principal investigator for an NIH funded R01 focusing on marriage and physical and mental health among older Mexican Americans, a core project for a NIH funded P50 Center for Population Health and Health Disparities examining the stress process among Mexican Americans, and two NIH subcontracts focusing on aging and ethnic variations in stress and stress-related biomarkers. Her publication record shows her expertise in the areas of stress, health disparities, mental health, Hispanic aging, and predictors of disability. She is an active researcher, mentor, and leader serving as Dean, ad interim, for the School of Public and Population Health, and Chair, ad interim, for the Department of Preventive Medicine and Population Health at the University of Texas Medical Branch. She recently completed her service as Vice Chair for Education in the Department of Preventive Medicine and Population Health, Associate Dean for Academic Affairs in the Graduate School of Biomedical Sciences, and Program Director for the Population Health Sciences PhD program. She has supervised many pre- and post-doctoral fellows in Population Health Sciences and has extensive administrative experience in course and curriculum evaluation and development, student assessments, educational accreditation, recruitment and admissions. Laura A. Pulscher, PhD, MSc USA Close Laura A. Pulscher, PhD, MSc Laura A. Pulscher, PhD, MSc is a Postdoctoral Fellow at the University of Texas Medical Branch in Galveston, Texas. Dr. Pulscher received her PhD at the University of Sydney in Sydney, Australia where she studied health related threats to the critically endangered Christmas Island flying-fox. She also holds a Master of Science in Global Health from Duke University where she studied the ecology of tick-borne pathogens in northern Mongolia. Dr. Pulscher is particularly interested in high consequence pathogens at the human, domestic animal, and wildlife interface. She has a varied background focused on human, animal, and environmental health and has studied a range of emerging pathogens including prions, respiratory and tick-borne pathogens across multiple countries. https://www.linkedin.com/in/laura-pulscher-91a2a9b0/ https://twitter.com/laurawildhealth Gayani Tillekeratne, MD, MSc, FIDSA USA Close Gayani Tillekeratne, MD, MSc, FIDSA Gayani Tillekeratne, MD MSc is an Assistant Professor in the Division of Infectious Diseases at Duke University School of Medicine and at the Duke Global Health Institute. She serves as an infectious diseases physician at the Durham Veterans Affairs Medical Center. Dr. Tillekeratne received her medical degree from Duke University School of Medicine in Durham, North Carolina and then completed her Internal Medicine residency training and Infectious Diseases fellowship training at the Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. She is board certified in Internal Medicine and Infectious Diseases. Dr Tillekeratne studies the epidemiology of acute respiratory tract infections and her work focuses on improving the diagnosis and management of these infections globally, especially with the goal of improving antimicrobial use. She is co-director of the Ruhuna-Duke Centre for Infectious Diseases in Sri Lanka and works with colleagues in Southeast Asia and East Africa. She is also a co-investigator for several US clinical trials for COVID-19 vaccines and therapeutics. Dr. Tillekeratne is a Fellow in the Infectious Diseases Society of America. Teck-Hock Toh, MBBS, FRCPCH Malaysia Close Teck-Hock Toh, MBBS, FRCPCH Teck-Hock Toh is a Pediatrician and the Head of the Clinical Research Center at Sibu Hospital and a Professor at the SEGi University Sibu Clinical Campus. He is also an Adjunct Professor for the School of Science and Technology at Sunway University, the Special Olympics Asia Pacific Regional Clinical Advisor in Health Promotion®, and the Vice President for the National Early Childhood Intervention Council.Professor Toh received his medical degree at the University of Melbourne and completed his pediatric training in the United Kingdom and Singapore. Besides general pediatrics, he also works in developmental-behavioral pediatrics, community child health and conduct researches in one-health infectious diseases and vaccine trials. Dr Toh has research experience for over 20 years and has collaborated with international institutions like Duke University, Universiti Malaya and Universiti Malaysia Sarawak, and those in Serbia, Singapore, and the Netherlands. He has authored more than 70 peer-reviewed manuscripts and book chapters. Others have cited his published works more than 300 times (H-index 11 by Google Scholar).Dr Toh has been invited to speak at various scientific meetings/conferences and conducted training on pediatrics, child health and research topics throughout Malaysia and internationally (ASEAN countries, Bangladesh, Australia, India, Hong Kong, and the United States). Besides scientific papers, he has also published parent-teacher handbooks on ADHD, language development, breastfeeding, and children reading / coloring books and books on Chinese literary prose and short stories. He received The Outstanding Young Malaysian Award in 2010 and Special Education Network in Asia Advocacy Award in 2018.https://www.linkedin.com/in/teck-hock-toh-456923144/ Sajid Umar, PhD, M.Phil, DVM China Close Sajid Umar, PhD, M.Phil, DVM Sajid Umar is a postdoctoral fellow/laboratory manager at One Health Research Laboratory, Duke Kunshan University (DKU),China. He received both his Bachelor’s degree (Veterinary Medicine, 2009) and his Master’s degree (Pathology, 2011) from University of Veterinary & Animal Sciences in Lahore, Pakistan. He received his PhD degree (Virology, 2017) from the National Veterinary School of Toulouse, France. He recently worked as a post-doctoral fellow studying animal respiratory viruses at the Department of Virology, Istanbul University, Turkey from 2018 to 2019. He has considerable experience in virological and molecular techniques and looks forward to working with DKU faculty, staff, and students. His current research interests continue to reside in the area of viral emerging infectious diseases, particularly zoonotic diseases that occur at the human and animal interface. He is specifically working on the epidemiology, virology, and molecular characterization of viruses that transmit among humans and animals, including influenza A/B/C/D viruses, coronavirus, enterovirus, and adenovirus. He is also overseeing projects focused on the laboratory animal research, the isolation of antimicrobial resistant genes in environmental samples, the isolation of influenza A viruses from pig samples, and developing new assays to detect antibodies against swine viruses in people. In addition, he is actively involved as a board member of DKU Institutional Animal Care and Use Committee and Laboratory Animal Research. Junfeng (Jim) Zhang, PhD USA Close Junfeng (Jim) Zhang, PhD Junfeng (Jim) Zhang is Professor of Global and Environmental Health at Duke University’s Nicholas School of the Environment, Duke Global Health Institute, and Duke Kunshan University. Prof. Zhang integrates clinical research, exposure science, toxicology, and epidemiology to examine health effects and underlying biological mechanisms of air pollution exposure (and other environmental contaminants and stressors). His recent work includes intervention trials to evaluate the effectiveness of using indoor air cleaning devices in improving cardiopulmonary health outcomes in adults and asthma outcomes in children. He directs the Exposure Biology and Chemistry Laboratory where his team develops novel biomarkers of pollutant exposure and biomarkers of pathophysiologic changes induced by pollutant exposure. These biomarkers have been used in a large number of field and lab-based studies to examine the health effects of ozone, particulate matter, diesel traffic, and the air pollution mixture. Dr. Zhang published more than 290 peer-reviewed articles in medical journals, environmental health journals, and environmental science journals. Dr. Zhang was recognized as a significant contributor to the 2007 Nobel Peace Prize awarded to the Inter-governmental Panel on Climate Change (IPCC). In 2012, Dr. Zhang received the Jerome Wesolowski Award, the highest honor of the International Society of Exposure Science. In 2013, Dr. Zhang was named an AAAS Fellow.